{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:43:54Z","timestamp":1792457034679,"version":"4.5.0"},"reference-count":136,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["pharmrev.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reviews"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1124\/pr.58.3.4","type":"journal-article","created":{"date-parts":[[2006,9,12]],"date-time":"2006-09-12T19:09:57Z","timestamp":1158088197000},"page":"463-487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":391,"title":["The Lipoxin Receptor ALX: Potent Ligand-Specific and Stereoselective Actions in Vivo"],"prefix":"10.1016","volume":"58","author":[{"given":"Nan","family":"Chiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles N.","family":"Serhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven-Erik","family":"Dahl\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Drazen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas W.P.","family":"Hay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Enrico","family":"Rovati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiko","family":"Yokomizo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Brink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/pr.58.3.4_REF1","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ni745","article-title":"Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity","volume":"3","author":"Aliberti","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1124\/pr.58.3.4_REF2","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1084\/jem.20021183","article-title":"Parasite-induced lipoxin A4 is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection","volume":"196","author":"Aliberti","year":"2002","journal-title":"J Exp Med"},{"key":"10.1124\/pr.58.3.4_REF3","doi-asserted-by":"crossref","first-page":"6266","DOI":"10.4049\/jimmunol.170.12.6266","article-title":"Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-\u03b1 secretion from human T cells","volume":"170","author":"Ariel","year":"2003","journal-title":"J Immunol"},{"key":"10.1124\/pr.58.3.4_REF4","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1084\/jem.20042031","article-title":"Stereochemical assignment, anti-inflammatory properties, and receptor for the \u03c9-3 lipid mediator resolvin E1","volume":"201","author":"Arita","year":"2005","journal-title":"J Exp Med"},{"key":"10.1124\/pr.58.3.4_REF5","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1073\/pnas.86.9.3438","article-title":"Lipoxin A4 antagonizes cellular and in vivo actions of leukotriene D4 in rat glomerular mesangial cells: evidence for competition at a common receptor","volume":"86","author":"Badr","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.4_REF6","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1172\/JCI23949","article-title":"Host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase-dependent lipoxin production","volume":"115","author":"Bafica","year":"2005","journal-title":"J Clin Investig"},{"key":"10.1124\/pr.58.3.4_REF7","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/j.1460-2075.1993.tb05814.x","article-title":"The probable arrangement of the helices in G protein-coupled receptors","volume":"12","author":"Baldwin","year":"1993","journal-title":"EMBO (Eur Mol Biol Organ) J"},{"key":"10.1124\/pr.58.3.4_REF8","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.4049\/jimmunol.164.5.2267","article-title":"Cutting edge (LX) Lipoxin: A4 and aspirin-triggered 15-epi-LXA4 block allergen-induced eosinophil trafficking","volume":"164","author":"Bandeira-Melo","year":"2000","journal-title":"J Immunol"},{"key":"10.1124\/pr.58.3.4_REF9","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.4049\/jimmunol.164.2.1029","article-title":"Cyclooxygenase-2-derived prostaglandin E2 and lipoxin A4 accelerate resolution of allergic edema in Angiostrongylus costaricensis-infected rats: relationship with concurrent eosinophilia","volume":"164","author":"Bandeira-Melo","year":"2000","journal-title":"J Immunol"},{"key":"10.1124\/pr.58.3.4_REF10","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1084\/jem.20031325","article-title":"Exogenous pathogen and plant 15-lipoxygenase initiate endogenous lipoxin A4 biosynthesis","volume":"199","author":"Bannenberg","year":"2004","journal-title":"J Exp Med."},{"key":"10.1124\/pr.58.3.4_REF11","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.4049\/jimmunol.174.7.4345","article-title":"Molecular circuits of resolution: formation and actions of resolvins and protectins","volume":"174","author":"Bannenberg","year":"2005","journal-title":"J Immunol"},{"key":"10.1124\/pr.58.3.4_REF12","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0888-7543(92)90265-T","article-title":"Mapping of genes for the human C5a receptor (C5AR), human FMLP receptor (FPR), and two FMLP receptor homologue orphan receptors (FPRH1, FPRH2) to chromosome 19","volume":"13","author":"Bao","year":"1992","journal-title":"Genomics"},{"key":"10.1124\/pr.58.3.4_REF13","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1164\/rccm.200201-053OC","article-title":"Lipoxins are potential endogenous anti-inflammatory mediators in asthma","volume":"165","author":"Bonnans","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1124\/pr.58.3.4_REF14","doi-asserted-by":"crossref","first-page":"11123","DOI":"10.1021\/bi00502a016","article-title":"The human N-formylpeptide receptor: characterization of two cDNA isolates and evidence for a new subfamily of G-protein-coupled receptors","volume":"29","author":"Boulay","year":"1990","journal-title":"Biochemistry"},{"key":"10.1124\/pr.58.3.4_REF15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0014-5793(89)80214-5","article-title":"Lipoxins stimulate prostacyclin generation by human endothelial cells","volume":"245","author":"Brezinski","year":"1989","journal-title":"FEBS Lett"},{"key":"10.1124\/pr.58.3.4_REF16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/bms.1200200202","article-title":"Characterization of lipoxins by combined gas chromatography and electron-capture negative ion chemical ionization mass spectrometry: formation of lipoxin A4 by stimulated human whole blood","volume":"20","author":"Brezinski","year":"1991","journal-title":"Biol Mass Spectrom"},{"key":"10.1124\/pr.58.3.4_REF17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1124\/pr.55.1.8","article-title":"International Union of Pharmacology. XXXVII. Nomenclature for leukotriene and lipoxin receptors","volume":"55","author":"Brink","year":"2003","journal-title":"Pharmacol Rev"},{"key":"10.1124\/pr.58.3.4_REF18","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1016\/j.bmcl.2006.04.068","article-title":"Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents","volume":"16","author":"Burli","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/pr.58.3.4_REF19","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1073\/pnas.052533799","article-title":"Lipid mediator-induced expression of bactericidal\/permeability-increasing protein (BPI) in human mucosal epithelia","volume":"99","author":"Canny","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.4_REF20","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1084\/jem.155.1.264","article-title":"Mitrochondrial N-formylmethionyl proteins as chemoattractants for neutrophils","volume":"155","author":"Carp","year":"1982","journal-title":"J Exp Med"},{"key":"10.1124\/pr.58.3.4_REF21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.plefa.2005.05.003","article-title":"Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX","volume":"73","author":"Chiang","year":"2005","journal-title":"Prostaglandins Leukotrienes Essent Fatty Acids"},{"key":"10.1124\/pr.58.3.4_REF22","doi-asserted-by":"crossref","first-page":"15178","DOI":"10.1073\/pnas.0405445101","article-title":"Aspirin triggers anti-inflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial","volume":"101","author":"Chiang","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.4_REF23","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1084\/jem.191.7.1197","article-title":"Activation of lipoxin A4 receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation","volume":"191","author":"Chiang","year":"2000","journal-title":"J Exp Med"},{"key":"10.1124\/pr.58.3.4_REF24","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1172\/JCI7016","article-title":"Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion","volume":"104","author":"Chiang","year":"1999","journal-title":"J Clin Investig"},{"key":"10.1124\/pr.58.3.4_REF25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/sj.bjp.0705220","article-title":"A novel rat lipoxin A4 receptor that is conserved in structure and function","volume":"139","author":"Chiang","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.58.3.4_REF26","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0022-3565(24)37857-7","article-title":"Aspirin-triggered 15-epi-lipoxin A4 (ATL) generation by human leukocytes and murine peritonitis exudates: development of a specific 15-epi-LXA4 ELISA","volume":"287","author":"Chiang","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.58.3.4_REF27","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1164\/ajrccm\/145.6.1281","article-title":"The effects of lipoxin A4 on airway responses in asthmatic subjects","volume":"145","author":"Christie","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1124\/pr.58.3.4_REF28","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/BF03401642","article-title":"Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation","volume":"2","author":"Cl\u00e0ria","year":"1996","journal-title":"Mol Med"},{"key":"10.1124\/pr.58.3.4_REF29","doi-asserted-by":"crossref","first-page":"9475","DOI":"10.1073\/pnas.92.21.9475","article-title":"Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions","volume":"92","author":"Cl\u00e0ria","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.4_REF30","doi-asserted-by":"crossref","first-page":"25372","DOI":"10.1074\/jbc.M002863200","article-title":"Oxidoreductases in lipoxin A4 metabolic inactivation","volume":"275","author":"Clish","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.58.3.4_REF31","doi-asserted-by":"crossref","first-page":"8247","DOI":"10.1073\/pnas.96.14.8247","article-title":"Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo","volume":"96","author":"Clish","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.4_REF32","series-title":"Lipoxygenases and Their Products","first-page":"235","article-title":"Lipoxins: bioactive lipoxygenase interaction products","author":"Dahl\u00e9n","year":"1991"},{"key":"10.1124\/pr.58.3.4_REF33","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1096\/fj.02-0770com","article-title":"Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host-defense","volume":"17","author":"Devchand","year":"2003","journal-title":"FASEB J"},{"key":"10.1124\/pr.58.3.4_REF34","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1096\/fj.04-2565com","article-title":"A synthetic eicosanoid LX-mimetic unravels host-donor interactions in allogeneic BMT-induced GvHD to reveal an early protective role for host neutrophils","volume":"19","author":"Devchand","year":"2005","journal-title":"FASEB J"},{"key":"10.1124\/pr.58.3.4_REF35","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.4049\/jimmunol.170.5.2688","article-title":"Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cells","volume":"170","author":"Fierro","year":"2003","journal-title":"J Immunol"},{"key":"10.1124\/pr.58.3.4_REF36","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1124\/jpet.300.2.385","article-title":"Novel lipid mediator regulators of endothelial cell proliferation and migration: aspirin-triggered-15R-lipoxin A4 and lipoxin A4","volume":"300","author":"Fierro","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.58.3.4_REF37","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1182\/blood.V94.12.4132","article-title":"Anti-inflammatory actions of lipoxin A4 stable analogs are demonstrable in human whole blood: modulation of leukocyte adhesion molecules and inhibition of neutrophil-endothelial interactions","volume":"94","author":"Filep","year":"1999","journal-title":"Blood"},{"key":"10.1124\/pr.58.3.4_REF38","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1084\/jem.180.1.253","article-title":"Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor","volume":"180","author":"Fiore","year":"1994","journal-title":"J Exp Med"},{"key":"10.1124\/pr.58.3.4_REF39","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1182\/blood.V81.12.3395.3395","article-title":"Induction of functional lipoxin A4 receptors in HL-60 cells","volume":"81","author":"Fiore","year":"1993","journal-title":"Blood"},{"key":"10.1124\/pr.58.3.4_REF40","doi-asserted-by":"crossref","first-page":"16168","DOI":"10.1016\/S0021-9258(18)41982-5","article-title":"Lipoxin recognition sites: specific binding of labeled lipoxin A4 with human neutrophils","volume":"267","author":"Fiore","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.58.3.4_REF41","doi-asserted-by":"crossref","first-page":"16678","DOI":"10.1021\/bi00051a016","article-title":"Lipoxin A4 receptor activation is distinct from that of the formyl peptide receptor in myeloid cells: inhibition of CD11\/18 expression by lipoxin A4-lipoxin A4 receptor interaction","volume":"34","author":"Fiore","year":"1995","journal-title":"Biochemistry"},{"key":"10.1124\/pr.58.3.4_REF42","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1053\/gast.2002.36558","article-title":"Cyclooxygenase-2-derived lipoxin A4 increases gastric resistance to aspirin-induced damage","volume":"123","author":"Fiorucci","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1124\/pr.58.3.4_REF43","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1021\/bi00531a009","article-title":"Formyl peptide chemoattractants: a model of the receptor on rabbit neutrophils","volume":"21","author":"Freer","year":"1982","journal-title":"Biochemistry"},{"key":"10.1124\/pr.58.3.4_REF44","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1021\/bi00552a019","article-title":"Further studies on the structural requirements for synthetic peptide chemoattractants","volume":"19","author":"Freer","year":"1980","journal-title":"Biochemistry"},{"key":"10.1124\/pr.58.3.4_REF45","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1189\/jlb.0905498","article-title":"Ligand recognition and activation of formyl peptide receptors in neutrophils","volume":"79","author":"Fu","year":"2006","journal-title":"J Leukoc Biol"},{"key":"10.1124\/pr.58.3.4_REF46","doi-asserted-by":"crossref","first-page":"5033","DOI":"10.4049\/jimmunol.174.8.5033","article-title":"Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung injury","volume":"174","author":"Fukunaga","year":"2005","journal-title":"J Immunol"},{"key":"10.1124\/pr.58.3.4_REF47","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1006\/geno.1998.5376","article-title":"Differential expansion of the N-formylpeptide receptor gene cluster in human and mouse","volume":"51","author":"Gao","year":"1998","journal-title":"Genomics"},{"key":"10.1124\/pr.58.3.4_REF48","doi-asserted-by":"crossref","first-page":"25395","DOI":"10.1016\/S0021-9258(19)74405-6","article-title":"Species and subtype variants of the N-formyl peptide chemotactic receptor reveal multiple important functional domains","volume":"268","author":"Gao","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.58.3.4_REF49","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1096\/fj.04-2178fje","article-title":"Formylpeptide receptor is not involved in the protection afforded by annexin 1 in murine acute myocardial infarct","volume":"19","author":"Gavins","year":"2005","journal-title":"FASEB J"},{"key":"10.1124\/pr.58.3.4_REF50","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1182\/blood-2002-11-3411","article-title":"Leukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related anti-inflammatory mechanisms","volume":"101","author":"Gavins","year":"2003","journal-title":"Blood"},{"key":"10.1124\/pr.58.3.4_REF51","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.4049\/jimmunol.168.10.5260","article-title":"Lipoxin A4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis","volume":"168","author":"Gewirtz","year":"2002","journal-title":"J Immunol"},{"key":"10.1124\/pr.58.3.4_REF52","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1172\/JCI1339","article-title":"Pathogen-induced chemokine secretion from model intestinal epithelium is inhibited by lipoxin A4 analogs","volume":"101","author":"Gewirtz","year":"1998","journal-title":"J Clin Investig"},{"key":"10.1124\/pr.58.3.4_REF53","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.4049\/jimmunol.164.4.1663","article-title":"Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages","volume":"164","author":"Godson","year":"2000","journal-title":"J Immunol"},{"key":"10.1124\/pr.58.3.4_REF54","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/0006-291X(90)90625-W","article-title":"Lipoxin A4 inhibits phosphoinositide hydrolysis in human neutrophils","volume":"167","author":"Grandordy","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pr.58.3.4_REF55","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1084\/jem.187.8.1285","article-title":"Identification of a human enterocyte lipoxin A4 receptor that is regulated by IL-13 and IFN-\u03b3 and inhibits TNF-\u03b1-induced IL-8 release","volume":"187","author":"Gronert","year":"1998","journal-title":"J Exp Med"},{"key":"10.1124\/pr.58.3.4_REF56","doi-asserted-by":"crossref","first-page":"15267","DOI":"10.1074\/jbc.M410638200","article-title":"A role for the mouse 12\/15-lipoxygenase pathway in promoting epithelial wound healing and host defense","volume":"280","author":"Gronert","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.58.3.4_REF57","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0002-9440(10)63937-5","article-title":"Selectivity of recombinant human leukotriene D4, leukotriene B4, and lipoxin A4 receptors with aspirin-triggered 15-epi-LXA4 and regulation of vascular and inflammatory responses","volume":"158","author":"Gronert","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1124\/pr.58.3.4_REF58","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1084\/jem.189.12.1923","article-title":"Lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor 1\u03b1-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis","volume":"189","author":"Hachicha","year":"1999","journal-title":"J Exp Med"},{"key":"10.1124\/pr.58.3.4_REF59","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1152\/physrev.1954.34.3.529","article-title":"Role of chemotaxis in inflammation","volume":"34","author":"Harris","year":"1954","journal-title":"Physiol Rev"},{"key":"10.1124\/pr.58.3.4_REF60","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1084\/jem.190.5.741","article-title":"N-Formylpeptides induce two distinct concentration optima for mouse neutrophil chemotaxis by differential interaction with two N-formylpeptide receptor (FPR) subtypes: molecular characterization of FPR2, a second mouse neutrophil FPR","volume":"190","author":"Hartt","year":"1999","journal-title":"J Exp Med"},{"key":"10.1124\/pr.58.3.4_REF61","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1182\/blood-2005-08-3099","article-title":"Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement","volume":"107","author":"Hayhoe","year":"2006","journal-title":"Blood"},{"key":"10.1124\/pr.58.3.4_REF61a","doi-asserted-by":"crossref","unstructured":"Hirai H, Tanaka K, Yoshie O, Ogawa K, Kenmotsu K, Takamori Y, Ichimasa M, Sugamura K, Nakamura M, Takano S, et al. Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med 193: 255-261.","DOI":"10.1084\/jem.193.2.255"},{"key":"10.1124\/pr.58.3.4_REF63","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/jcb.240200209","article-title":"The fate of the N-formyl-chemotactic peptide receptor in stimulated human granulocytes: subcellular fractionation studies","volume":"20","author":"Jesaitis","year":"1982","journal-title":"J Cell Biochem"},{"key":"10.1124\/pr.58.3.4_REF64","doi-asserted-by":"crossref","first-page":"13266","DOI":"10.1073\/pnas.202296999","article-title":"Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-\u03baB and AP-1 activation, and IL-8 gene expression in human leukocytes","volume":"99","author":"Jozsef","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.4_REF65","doi-asserted-by":"crossref","first-page":"13551","DOI":"10.1021\/bi001196i","article-title":"Mutations of serine 235-237 and tyrosine 302 residues in the human lipoxin A4 receptor intracellular domains result in sustained signaling","volume":"39","author":"Kang","year":"2000","journal-title":"Biochemistry"},{"key":"10.1124\/pr.58.3.4_REF66","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/ni1056","article-title":"Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway","volume":"5","author":"Karp","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1124\/pr.58.3.4_REF67","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0165-6147(97)01136-X","article-title":"Differences between natural and recombinant G protein-coupled receptor systems with varying receptor\/G protein stoichiometry","volume":"18","author":"Kenakin","year":"1997","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/pr.58.3.4_REF68","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nrd722","article-title":"Efficacy at G-protein-coupled receptors","volume":"1","author":"Kenakin","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/pr.58.3.4_REF69","doi-asserted-by":"crossref","first-page":"16316","DOI":"10.1016\/S0021-9258(19)85423-6","article-title":"N-linked glycosylation of the receptor for murine ecotropic retroviruses is altered in virus-infected cells","volume":"268","author":"Kim","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.58.3.4_REF70","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1172\/JCI17545","article-title":"An angiogenic role for the human peptide antibiotic LL-37\/hCAP-18","volume":"111","author":"Koczulla","year":"2003","journal-title":"J Clin Investig"},{"key":"10.1124\/pr.58.3.4_REF71","doi-asserted-by":"crossref","first-page":"C888","DOI":"10.1152\/ajpcell.00507.2001","article-title":"Lateral membrane LXA4 receptors mediate LXA4\u2019s anti-inflammatory actions on intestinal epithelium","volume":"284","author":"Kucharzik","year":"2003","journal-title":"Am J Physiol"},{"key":"10.1124\/pr.58.3.4_REF72","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S1471-4906(02)02316-5","article-title":"Formyl-peptide receptors revisited","volume":"23","author":"Le","year":"2002","journal-title":"Trends Immunol"},{"key":"10.1124\/pr.58.3.4_REF73","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1042\/cs0770195","article-title":"Lipoxin A4 and lipoxin B4 inhibit chemotactic responses of human neutrophils stimulated by leukotriene B4 and N-formyl-l-methionyl-l-leucyl-l-phenylalanine","volume":"77","author":"Lee","year":"1989","journal-title":"Clin Sci"},{"key":"10.1124\/pr.58.3.4_REF74","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1096\/fasebj.13.8.903","article-title":"Polyisoprenyl phosphate (PIPP) signaling regulates phospholipase D activity: a \u201cstop\u201d signaling switch for aspirin-triggered lipoxin A4","volume":"13","author":"Levy","year":"1999","journal-title":"FASEB J"},{"key":"10.1124\/pr.58.3.4_REF75","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1172\/JCI116738","article-title":"Human alveolar macrophages have 15-lipoxygenase and generate 15(S)-hydroxy-5,8,11-cis-13-trans-eicosatetraenoic acid and lipoxins","volume":"92","author":"Levy","year":"1993","journal-title":"J Clin Investig"},{"key":"10.1124\/pr.58.3.4_REF76","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/nm748","article-title":"Multi-pronged inhibition of airway hyperresponsiveness and inflammation by lipoxin A4","volume":"8","author":"Levy","year":"2002","journal-title":"Nat Med"},{"key":"10.1124\/pr.58.3.4_REF77","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nm1355","article-title":"Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent","volume":"12","author":"Machado","year":"2006","journal-title":"Nat Med"},{"key":"10.1124\/pr.58.3.4_REF78","doi-asserted-by":"crossref","first-page":"6972","DOI":"10.1074\/jbc.272.11.6972","article-title":"Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein linked lipoxin A4 receptor","volume":"272","author":"Maddox","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.58.3.4_REF79","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1084\/jem.183.1.137","article-title":"Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction","volume":"183","author":"Maddox","year":"1996","journal-title":"J Exp Med"},{"key":"10.1124\/pr.58.3.4_REF80","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/S0002-9440(10)61175-3","article-title":"Lipoxins induce actin reorganization in monocytes and macrophages but not in neutrophils: differential involvement of rho GTPases","volume":"160","author":"Maderna","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1124\/pr.58.3.4_REF81","doi-asserted-by":"crossref","first-page":"C945","DOI":"10.1152\/ajpcell.2000.279.4.C945","article-title":"Influence of lipoxin A4 and other lipoxygenase-derived eicosanoids on tissue factor expression","volume":"279","author":"Maderna","year":"2000","journal-title":"Am J Physiol"},{"key":"10.1124\/pr.58.3.4_REF82","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.4049\/jimmunol.174.6.3727","article-title":"Modulation of phagocytosis of apoptotic neutrophils by supernatant from dexamethasone-treated macrophages and annexin-derived peptide Ac(2-26)","volume":"174","author":"Maderna","year":"2005","journal-title":"J Immunol"},{"key":"10.1124\/pr.58.3.4_REF83","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/ki.1996.190","article-title":"Acute passive anti-glomerular basement membrane nephritis in P-selectin-deficient mice","volume":"49","author":"Mayadas","year":"1996","journal-title":"Kidney Int"},{"key":"10.1124\/pr.58.3.4_REF84","first-page":"355A","article-title":"Modulation of mesangial cell MAP kinase activities by leukotriene D4 and lipoxin A4","volume":"9","author":"McMahon","year":"1998","journal-title":"JAmSoc Nephrol"},{"key":"10.1124\/pr.58.3.4_REF85","first-page":"1817","article-title":"Lipoxin, leukotriene, and PDGF receptors cross-talk to regulate mesangial cell proliferation","volume":"16","author":"McMahon","year":"2002","journal-title":"FASEB J"},{"key":"10.1124\/pr.58.3.4_REF86","doi-asserted-by":"crossref","first-page":"27566","DOI":"10.1074\/jbc.M001015200","article-title":"Lipoxin A4 antagonizes the mitogenic effects of leukotriene D4 in human renal mesangial cells: differential activation of MAP kinases through distinct receptors","volume":"275","author":"McMahon","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.58.3.4_REF87","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.4049\/jimmunol.159.8.4045","article-title":"The ligand binding site of the formyl peptide receptor maps in the transmembrane region","volume":"159","author":"Miettinen","year":"1997","journal-title":"J Immunol"},{"key":"10.1124\/pr.58.3.4_REF88","series-title":"Molecular and Cellular Basis of inflammation","first-page":"215","article-title":"The N-formyl peptide receptor: structure, signaling and disease","author":"Mills","year":"1999"},{"key":"10.1124\/pr.58.3.4_REF89","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1097\/01.ASN.0000032417.73640.72","article-title":"Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo","volume":"13","author":"Mitchell","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/pr.58.3.4_REF90","doi-asserted-by":"crossref","first-page":"13375","DOI":"10.1073\/pnas.96.23.13375","article-title":"Transfection of rat kidney with human 15-lipoxygenase suppresses inflammation and preserves function in experimental glomerulonephritis","volume":"96","author":"Munger","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.4_REF91","doi-asserted-by":"crossref","first-page":"7637","DOI":"10.1016\/S0021-9258(18)42563-X","article-title":"A structural homologue of the N-formyl peptide receptor: characterization and chromosomal mapping of a peptide chemoattractant receptor gene family","volume":"267","author":"Murphy","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.58.3.4_REF92","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.4049\/jimmunol.162.3.1278","article-title":"Selective expression of a novel surface molecule by human Th2 cells in vivo","volume":"162","author":"Nagata","year":"1999","journal-title":"J Immunol"},{"key":"10.1124\/pr.58.3.4_REF93","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1152\/physrev.1999.79.4.1193","article-title":"Prostanoid receptors: structures, properties, and functions","volume":"79","author":"Narumiya","year":"1999","journal-title":"Physiol Rev"},{"key":"10.1124\/pr.58.3.4_REF94","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nature01320","article-title":"Points of control in inflammation","volume":"420","author":"Nathan","year":"2002","journal-title":"Nature (Lond)"},{"key":"10.1124\/pr.58.3.4_REF95","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/jcp.1041430316","article-title":"Lipoxin A4 and lipoxin B4 stimulate the release but not the oxygenation of arachidonic acid in human neutrophils: dissociation between lipid remodeling and adhesion","volume":"143","author":"Nigam","year":"1990","journal-title":"J Cell Physiol"},{"key":"10.1124\/pr.58.3.4_REF96","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/intimm\/5.10.1239","article-title":"Molecular cloning of cDNAs encoding a LD78 receptor and putative leukocyte chemotactic peptide receptors","volume":"5","author":"Nomura","year":"1993","journal-title":"Int Immunol"},{"key":"10.1124\/pr.58.3.4_REF97","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.pharmthera.2004.05.003","article-title":"The quest for new cysteinyl-leukotriene and lipoxin receptors: recent clues","volume":"103","author":"Norel","year":"2004","journal-title":"Pharmacol Ther"},{"key":"10.1124\/pr.58.3.4_REF98","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.4049\/jimmunol.173.3.2091","article-title":"A stable aspirin-triggered lipoxin A4 analog blocks phosphorylation of leukocyte-specific protein 1 in human neutrophils","volume":"173","author":"Ohira","year":"2004","journal-title":"J Immunol"},{"key":"10.1124\/pr.58.3.4_REF99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/0022-1317-47-1-1","article-title":"Altered kinetic properties of sialyl and galactosyl transferases associated with herpes simplex virus infection of GMK and BHK cells","volume":"47","author":"Olofsson","year":"1980","journal-title":"J Gen Virol"},{"key":"10.1124\/pr.58.3.4_REF100","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.4049\/jimmunol.156.6.2264","article-title":"Lipoxin A4 and B4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells","volume":"156","author":"Papayianni","year":"1996","journal-title":"J Immunol"},{"key":"10.1124\/pr.58.3.4_REF101","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1084\/jem.20040566","article-title":"15-Epi-lipoxin A4-mediated induction of nitric oxide explains how aspirin inhibits acute inflammation","volume":"200","author":"Paul-Clark","year":"2004","journal-title":"J Exp Med"},{"key":"10.1124\/pr.58.3.4_REF102","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0378-1119(92)90208-7","article-title":"Cloning of a cDNA encoding a receptor related to the formyl peptide receptor of human neutrophils","volume":"118","author":"Perez","year":"1992","journal-title":"Gene (Amst)"},{"key":"10.1124\/pr.58.3.4_REF103","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/nm786","article-title":"Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor","volume":"8","author":"Perretti","year":"2002","journal-title":"Nat Med"},{"key":"10.1124\/pr.58.3.4_REF104","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1096\/fj.02-0224fje","article-title":"Aspirin (ASA) regulates 5-lipoxygenase activity and peroxisome proliferator-activated receptor \u03b1-mediated CINC-1 release in rat liver cells: novel actions of lipoxin A4 (LXA4) and ASA-triggered 15-epi-LXA4","volume":"16","author":"Planagum\u00e0","year":"2002","journal-title":"FASEB J"},{"key":"10.1124\/pr.58.3.4_REF105","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1021\/bi992551b","article-title":"Lipoxin A4 analogues inhibit leukocyte recruitment to Porphyromonas gingivalis: a role for cyclooxygenase-2 and lipoxins in periodontal disease","volume":"39","author":"Pouliot","year":"2000","journal-title":"Biochemistry"},{"key":"10.1124\/pr.58.3.4_REF106","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1096\/fj.01-0576fje","article-title":"Aspirin-triggered lipoxin A4 and lipoxin A4 up-regulate transcriptional corepressor NAB1 in human neutrophils","volume":"15","author":"Qiu","year":"2001","journal-title":"FASEB J"},{"key":"10.1124\/pr.58.3.4_REF107","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1002\/eji.200526338","article-title":"Human mitochondria-derived N-formylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes-derived peptides preferentially activate FPR","volume":"35","author":"Rabiet","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1124\/pr.58.3.4_REF108","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4049\/jimmunol.138.1.266","article-title":"Lipoxin A-induced inhibition of human natural killer cell cytotoxicity: studies on stereospecificity of inhibition and mode of action","volume":"138","author":"Ramstedt","year":"1987","journal-title":"J Immunol"},{"key":"10.1124\/pr.58.3.4_REF109","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1465-9921-7-42","article-title":"CysLT1 receptor-induced human airway smooth muscle cells proliferation requires ROS generation, EGF receptor transactivation and ERK1\/2 phosphorylation","volume":"7","author":"Ravasi","year":"2006","journal-title":"Resp Res"},{"key":"10.1124\/pr.58.3.4_REF110","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1073\/pnas.022652999","article-title":"The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1\/LXA4R","volume":"99","author":"Resnati","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.4_REF111","doi-asserted-by":"crossref","first-page":"8269","DOI":"10.1021\/bi00150a021","article-title":"Lipoxin generation by permeabilized human platelets","volume":"31","author":"Romano","year":"1992","journal-title":"Biochemistry."},{"key":"10.1124\/pr.58.3.4_REF112","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.4049\/jimmunol.157.5.2149","article-title":"Activation of human monocytes and the acute monocytic leukemia cell line (THP-1) by lipoxins involves unique signaling pathways for lipoxin A4 versus lipoxin B4","volume":"157","author":"Romano","year":"1996","journal-title":"J Immunol"},{"key":"10.1124\/pr.58.3.4_REF113","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1126\/science.2820055","article-title":"Leukotrienes and lipoxins: structures, biosynthesis, and biological effects","volume":"237","author":"Samuelsson","year":"1987","journal-title":"Science (Wash DC)"},{"key":"10.1124\/pr.58.3.4_REF114","doi-asserted-by":"crossref","first-page":"9967","DOI":"10.1073\/pnas.94.18.9967","article-title":"Lipoxin A4 stable analogs inhibit leukocyte rolling and adherence in the rat mesenteric microvasculature: role of P-selectin","volume":"94","author":"Scalia","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.58.3.4_REF115","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1021\/bi982861e","article-title":"Lipoxin A4: a new class of ligand for the Ah receptor","volume":"38","author":"Schaldach","year":"1999","journal-title":"Biochemistry"},{"key":"10.1124\/pr.58.3.4_REF116","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.4049\/jimmunol.114.6.1831","article-title":"The isolation and partial characterization of neutrophil chemotactic factors from Escherichia coli","volume":"114","author":"Schiffmann","year":"1975","journal-title":"J Immunol"},{"key":"10.1124\/pr.58.3.4_REF117","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0090-6980(97)00001-4","article-title":"Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity?","volume":"53","author":"Serhan","year":"1997","journal-title":"Prostaglandins"},{"key":"10.1124\/pr.58.3.4_REF118","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.prostaglandins.2004.03.005","article-title":"Resolvins, docosatrienes, and neuroprotectins, novel \u03c9-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis","volume":"73","author":"Serhan","year":"2004","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1124\/pr.58.3.4_REF119","doi-asserted-by":"crossref","first-page":"6856","DOI":"10.4049\/jimmunol.171.12.6856","article-title":"Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators","volume":"171","author":"Serhan","year":"2003","journal-title":"J Immunol"},{"key":"10.1124\/pr.58.3.4_REF120","doi-asserted-by":"crossref","first-page":"14609","DOI":"10.1021\/bi00044a041","article-title":"Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils","volume":"34","author":"Serhan","year":"1995","journal-title":"Biochemistry"},{"key":"10.1124\/pr.58.3.4_REF121","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1172\/JCI119029","article-title":"Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development","volume":"98","author":"Shen","year":"1996","journal-title":"J Clin Investig"},{"key":"10.1124\/pr.58.3.4_REF122","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1084\/jem.143.5.1154","article-title":"The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal secretion for neutrophils","volume":"143","author":"Showell","year":"1976","journal-title":"J Exp Med"},{"key":"10.1124\/pr.58.3.4_REF123","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/039463200401700103","article-title":"Lipoxin A4 counteracts synergistic activation of human fibroblast-like synoviocytes","volume":"17","author":"Sodin-Semrl","year":"2004","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1124\/pr.58.3.4_REF124","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/039463200401700206","article-title":"Opposing regulation of interleukin-8 and NF-\u03baB responses by lipoxin A4 and serum amyloid A via the common lipoxin A receptor","volume":"17","author":"Sodin-Semrl","year":"2004","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1124\/pr.58.3.4_REF125","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.4049\/jimmunol.164.5.2660","article-title":"Lipoxin A4 inhibits IL-1 \u03b2-induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases","volume":"164","author":"Sodin-Semrl","year":"2000","journal-title":"J Immunol"},{"key":"10.1124\/pr.58.3.4_REF126","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0006-291X(05)81285-9","article-title":"Formation and proliferative effects of lipoxins in human bone marrow","volume":"180","author":"Stenke","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pr.58.3.4_REF127","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1172\/JCI1578","article-title":"Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues","volume":"101","author":"Takano","year":"1998","journal-title":"J Clin Investig"},{"key":"10.1124\/pr.58.3.4_REF128","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1084\/jem.185.9.1693","article-title":"Aspirin-triggered 15-epi-lipoxin A4 and LXA4 stable analogs are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors","volume":"185","author":"Takano","year":"1997","journal-title":"J Exp Med"},{"key":"10.1124\/pr.58.3.4_REF129","doi-asserted-by":"crossref","first-page":"C870","DOI":"10.1152\/ajpcell.1999.277.5.C870","article-title":"Hepatocytes are a rich source of novel aspirin-triggered 15-epi-lipoxin A4 (ATL)","volume":"277","author":"Titos","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1124\/pr.58.3.4_REF130","series-title":"Les Prix Nobel: Nobel Prizes, Presentations, Biographies and Lectures","first-page":"181","article-title":"Adventures and excursions in bioassay: the stepping stones to prostacyclin","author":"Vane","year":"1982"},{"key":"10.1124\/pr.58.3.4_REF131","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.4049\/jimmunol.169.6.3363","article-title":"Identification, cloning, and functional characterization of a murine lipoxin A4 receptor homologue gene","volume":"169","author":"Vaughn","year":"2002","journal-title":"J Immunol"},{"key":"10.1124\/pr.58.3.4_REF132","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1084\/jem.180.6.2137","article-title":"Infection with Listeria monocytogenes impairs sialic acid addition to host cell glycoproteins","volume":"180","author":"Villanueva","year":"1994","journal-title":"J Exp Med"},{"key":"10.1124\/pr.58.3.4_REF133","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0378-1119(02)01012-0","article-title":"Characterization of two new members of the formyl peptide receptor gene family from 129S6 mice","volume":"299","author":"Wang","year":"2002","journal-title":"Gene."},{"key":"10.1124\/pr.58.3.4_REF134","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/sj.ki.5000025","article-title":"Lipoxin A4 inhibits connective tissue growth factor-induced production of chemokines in rat mesangial cells","volume":"69","author":"Wu","year":"2006","journal-title":"Kidney Int"},{"key":"10.1124\/pr.58.3.4_REF135","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/0006-291X(92)90629-Y","article-title":"Isolation of a cDNA that encodes a novel granulocyte N-formyl peptide receptor","volume":"184","author":"Ye","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pr.58.3.4_REF136","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/42506","article-title":"A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis","volume":"387","author":"Yokomizo","year":"1997","journal-title":"Nature (Lond)"}],"container-title":["Pharmacological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699724116833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699724116833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/pr.58.3.4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T03:09:05Z","timestamp":1738552145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031699724116833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":136,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0031699724116833"],"URL":"https:\/\/doi.org\/10.1124\/pr.58.3.4","relation":{},"ISSN":["0031-6997"],"issn-type":[{"value":"0031-6997","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Lipoxin Receptor ALX: Potent Ligand-Specific and Stereoselective Actions in Vivo","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/pr.58.3.4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}